Endovascular Repair of AAA
Sponsor
Assiut University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05808439
Collaborator
(none)
50
2
7
25
3.6
Study Details
Study Description
Brief Summary
We study differen t endovascular techniques as an alternative to surgical reconstruction to repair AAAS regarding ; success rates, 30-day mortality, endoleak events secondary intervention rates
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Endovascular Abdominal Aortic Aneurysm Repair
Anticipated Study Start Date
:
Apr 15, 2023
Anticipated Primary Completion Date
:
Oct 15, 2023
Anticipated Study Completion Date
:
Nov 15, 2023
Outcome Measures
Primary Outcome Measures
- 30 day mortality [30 days]
Total death
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Older than 18
Exclusion Criteria:
- inflammatory or mycotic AAA
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Assuit | Assiut | Assuit | Egypt | 7777 |
| 2 | Assuit | Assuit | Egypt | 7777 |
Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Khaled Mohamed Awad Hassan,
Assistant lecturer,
Assiut University
ClinicalTrials.gov Identifier:
NCT05808439
Other Study ID Numbers:
- Endovascular repair of AAa
First Posted:
Apr 11, 2023
Last Update Posted:
Apr 11, 2023
Last Verified:
Mar 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: